Cited by 385Barrier Structure and Function StudiesMultiple Sclerosis Research StudiesDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Role of the Blood–Brain Barrier in Multiple Sclerosis

Ortiz, Genaro Gabriel, Pacheco-Moisés, Fermín Paul, Macías-Islas, Miguel Ángel, Flores-Alvarado, Luis Javier, Mireles-Ramírez, Mario A., González-Renovato, Erika Daniela, Hernández-Navarro, Vanessa Elizabeth, Sánchez-López, Angélica Lizeth, Alatorre-Jiménez, Moisés Alejandro·2014·Archives of Medical Research

DOI 10.1016/j.arcmed.2014.11.013

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system associated with demyelination and axonal loss eventually leading to neurodegeneration. MS exhibits many of the hallmarks of an inflammatory autoimmune disorder including breakdown of the blood-brain barrier (BBB). The BBB is a complex organization of cerebral endothelial cells, pericytes and their basal lamina, which are surrounded and supported by astrocytes and perivascular macrophages. In pathological conditions, lymphocytes activated in the periphery infiltrate the central nervous system to trigger a local immune response that ultimately damages myelin and axons. Cytotoxic factors including pro-inflammatory cytokines, proteases, and reactive oxygen and nitrogen species accumulate and may contribute to myelin destruction. Dysregulation of the BBB and transendothelial migration of activated leukocytes are among the earliest cerebrovascular abnormalities seen in MS brains and parallel the release of inflammatory cytokines. In this review we establish the importance of the role of the BBB in MS. Improvements in our understanding of molecular mechanism of BBB functioning in physiological and pathological conditions could lead to improvement in the quality of life of MS patients.

Integrity signals

Registry

Crossref · 10.1016/j.arcmed.2014.11.013

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin
Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1539 · Cited by 2,100
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Mfsd2a is critical for the formation and function of the blood-brain barrier
Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., & Gu, C. (2014) · Nature · doi:10.1038/nature13324 · Cited by 1,037
The anatomical and cellular basis of immune surveillance in the central nervous system
Ransohoff, R. M., & Engelhardt, B. (2012) · Nature reviews. Immunology · doi:10.1038/nri3265 · Cited by 1,029
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. J., & Mills, K. H. G. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 975
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology
Griendling, K. K., Sorescu, D., Lassegue, B. P., & Ushio‐Fukai, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
Nitric Oxide Production and Signaling in Inflammation
Korhonen, R., Lahti, A., Kankaanranta, H., & Moilanen, E. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010054526359 · Cited by 920
Nitric oxide and redox mechanisms in the immune response
Wink, D. A., Hines, H. B., Cheng, R. Y. S., Switzer, C. H., Flores-Santana, W., Vitek, M. P., Ridnour, L. A., & Colton, C. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1010550 · Cited by 765
Free Radical Pathways in CNS Injury
LEWÉN, A., MATZ, P., & CHAN, P. H. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.871 · Cited by 759
Conversion of Zonulae Occludentes from Tight to Leaky Strand Type by Introducing Claudin-2 into Madin-Darby Canine Kidney I Cells
Furuse, M., Furuse, K., Sasaki, H., & Tsukita, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.263 · Cited by 712
Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells
Anderson, A. C., Anderson, D. E., Bregoli, L., Hastings, W. D., Kassam, N., Lei, C., Chandwaskar, R., Kármán, J., Su, E. W., Hirashima, M., et al. (2007) · Science · doi:10.1126/science.1148536 · Cited by 703
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 601
Trafficking of immune cells in the central nervous system
Wilson, E. H., Weninger, W., & Hunter, C. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41911 · Cited by 547
Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 544
Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D
Ramagopalan, S. V., Maugeri, N., Handunnetthi, L., Lincoln, M. R., Orton, S. M., Dyment, D. A., DeLuca, G. C., Herrera, B. M., Chao, M. J., Sadovnick, A. D., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000369 · Cited by 540
The role of nitric oxide in multiple sclerosis
Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 535
Nanoparticles for Brain Drug Delivery
Masserini, M. (2013) · ISRN Biochemistry · doi:10.1155/2013/238428 · Cited by 507
Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme
Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Acta Neuropathologica · doi:10.1007/s004010000180 · Cited by 490
Oxidative stress in Alzheimer disease: A possibility for prevention
Bonda, D., Wang, X., Perry, G. L., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 487
Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis.
Bagasra, O., Michaels, F. H., Zheng, Y., Bobroski, L. E., Spitsin, S. V., Fu, Z., Tawadros, R., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12041 · Cited by 456
The role of shear stress in Blood-Brain Barrier endothelial physiology
Cucullo, L., Hossain, M., Puvenna, V., Marchi, N., & Janigro, D. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-40 · Cited by 455
Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme
Wolburg, H., Wolburg‐Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.-H., Risau, W., & Engelhardt, B. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0688-z · Cited by 454
Neurological Diseases in Relation to the Blood–Brain Barrier
Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 454
T cells become licensed in the lung to enter the central nervous system
Odoardi, F., Sie, C., Streyl, K., Ulaganathan, V. K., Schläger, C., Lodygin, D., Heckelsmiller, K., Nietfeld, W., Ellwart, J. W., Klinkert, W. E. F., et al. (2012) · Nature · doi:10.1038/nature11337 · Cited by 453
Induction of MHC Class I Genes in Neurons
Neumann, H., Cavalié, A., Jenne, D. E., & Wekerle, H. (1995) · Science · doi:10.1126/science.7624779 · Cited by 451
Drug delivery to the central nervous system: a review.
Misra, A. R., Ganesh, S. D., Shahiwala, A., & Shah, S. P. (2003) · PubMed · Cited by 435
Mechanisms of the Antioxidant Effects of Nitric Oxide
Wink, D. A., Miranda, K. M., Espey, M. G., Pluta, R. M., Hewett, S. J., Colton, C. A., Vitek, M. P., Feelisch, M., & Grisham, M. B. (2001) · Antioxidants and Redox Signaling · doi:10.1089/152308601300185179 · Cited by 400
Drug delivery to the central nervous system: A review
Tamargo, R. J., & Brem, H. (1992) · Neurosurgery Quarterly · Cited by 369
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
Disruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab
Steinman, L. (2005) · Nature reviews. Drug discovery · doi:10.1038/nrd1752 · Cited by 328
Astrocytes in multiple sclerosis: A product of their environment
Nair, A., Frederick, T., & Miller, S. D. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8059-5 · Cited by 323
B cells and multiple sclerosis
Franciotta, D. M., Salvetti, M., Lolli, F., Serafini, B., & Aloisi, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70192-3 · Cited by 286
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
Rostami, A. M., & Ćirić, B. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.002 · Cited by 283
Local Overexpression of V1a-Vasopressin Receptor Enhances Regeneration in Tumor Necrosis Factor-Induced Muscle Atrophy
Costa, A., Toschi, A., Murfuni, I., Pelosi, L., Sica, G., Adamo, S., & Scicchitano, B. M. (2014) · BioMed Research International · doi:10.1155/2014/235426 · Cited by 248
The Structure and Function of Claudins, Cell Adhesion Molecules at Tight Junctions
Tsukita, S., & Furuse, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05235.x · Cited by 247
The blood-brain barrier, chemokines and multiple sclerosis
Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247
Macrophages and neurodegeneration
Hendriks, J. J. A., Teunissen, C. E., de Vries, H. E., & Dijkstra, C. D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.008 · Cited by 247
Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis
Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242
Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI
Cramer, S. P., Simonsen, H., Frederiksen, J. L., Rostrup, E., & Larsson, H. B. W. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.12.001 · Cited by 232 · cited 1×
“According to one major theory proposed by Poser in 1986 (10), four elements are required in order to develop MS: a) genetic susceptibility, b) environmental and probably viral immune-mediated event, c) alteration of the BBB function d) myelinoclastic plaqueforming capability in the CNS (19).”
Background
Inflammatory mediators in demyelinating disorders of the CNS and PNS
Hartung, H., Jung, S., Stoll, G., Zielasek, J., Schmidt, B. G., Archelos, J. J., & Toyka, K. V. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90134-7 · Cited by 213
Remyelination in multiple sclerosis
Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191
The Crosstalk between the Bone and the Immune System: Osteoimmunology
Brunetti, G., Mori, G., D’Amelio, P., & Faccio, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/617319 · Cited by 188
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
Bellavance, M., Blanchette, M., & Fortin, D. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9018-7 · Cited by 183
Reactive oxygen species are required for the phagocytosis of myelin by macrophages
van der Goes, A., Brouwer, J. P., Hoekstra, K., Roos, D., van den Berg, T. K., & Dijkstra, C. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00175-1 · Cited by 180
Multiple Sclerosis and Regulatory T Cells
Costantino, C. M., Baecher‐Allan, C., & Hafler, D. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9236-x · Cited by 167
Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity
Schreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., van Kesteren-Hendrikx, E. M. L., Döpp, E. A., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2630 · Cited by 167
Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S‐nitrosothiols and with changes in glutathione levels
Calabrese, V., Scapagnini, G., Ravagna, A., Bella, R., Foresti, R., Bates, T. E., Stella, A. G., & Pennisi, G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10408 · Cited by 163
Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro
van der Goes, A., Wouters, D., van der Pol, S. M. A., Huizinga, R., Ronken, E., Adamson, P., Greenwood, J., Dijkstra, C. D., & de Vries, H. E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0881fje · Cited by 162
Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160
Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage
Hill, K. E., Zollinger, L. V., Watt, H. E., Carlson, N. G., & Rose, J. W. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.005 · Cited by 158
Natalizumab: Targeting α4-Integrins in Multiple Sclerosis
Engelhardt, B., & Kappos, L. (2007) · Neurodegenerative Diseases · doi:10.1159/000109933 · Cited by 156
Astrocyte–neuron interactions in neurological disorders
Ricci, G., Volpi, L., Pasquali, L., Petrozzi, L., & Siciliano, G. (2009) · Journal of Biological Physics · doi:10.1007/s10867-009-9157-9 · Cited by 155
Cytokine‐stimulated inducible nitric oxide synthase expression in astroglia: Role of Erk mitogen‐activated protein kinase and NF‐κB
Marcus, J. S., Karackattu, S. L., Fleegal, M. A., & Sumners, C. (2002) · Glia · doi:10.1002/glia.10168 · Cited by 120
Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Hernández‐Pedro, N., Espinosa-Ramírez, G., de la Cruz, V. P., Pineda, B., & Sotelo, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/413465 · Cited by 113
The potential role of nitric oxide in multiple sclerosis
Giovannoni, G., Heales, S., Land, J. M., & Thompson, E. J. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400323 · Cited by 113
IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS
Waubant, E. L., Goodkin, D., Bostrom, A., Bacchetti, P., Hietpas, J., Lindberg, R. L. P., & Leppert, D. (2003) · Neurology · doi:10.1212/wnl.60.1.52 · Cited by 105
Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic Barrier
Minn, A., Leclerc, S., Heydel, J., Minn, A.-L., Denizot, C., Cattarelli, M., Netter, P., & Grădinaru, D. (2002) · Journal of drug targeting · doi:10.1080/713714452 · Cited by 104
Regulation of claudins in blood-tissue barriers under physiological and pathological states
Gonçalves, A., Ambrósio, A. F., & Fernandes, R. (2013) · Tissue Barriers · doi:10.4161/tisb.24782 · Cited by 90
Promoting Remyelination in Multiple Sclerosis—Recent Advances
Muenzel, E. J., & Williams, A. (2013) · Drugs · doi:10.1007/s40265-013-0146-8 · Cited by 89
Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,
Shinto, L. H., Marracci, G., Baldauf-Wagner, S., Strehlow, A., Yadav, V., Stuber, L. E., & BOURDETTE, D. N. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.12.001 · Cited by 88
Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease
Meeteren, M. E. V., Hendriks, J. J. A., Dijkstra, C. D., & van Tol, E. A. F. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.018 · Cited by 84
Role of puberty in multiple sclerosis risk and course
Chitnis, T. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.03.014 · Cited by 84
Environmental triggers of multiple sclerosis
Kakalacheva, K., & Lünemann, J. D. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.006 · Cited by 83
The Role of ER Stress-Induced Apoptosis in Neurodegeneration
Stefani, I. C., Wright, D., Polizzi, K. M., & Kontoravdi, C. (2012) · Current Alzheimer Research · doi:10.2174/156720512800107618 · Cited by 83
H2O2-mediated permeability II: importance of tyrosine phosphatase and kinase activity
Kevil, C. G., Okayama, N., & Alexander, J. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.6.c1940 · Cited by 74
Functions of lipid raft membrane microdomains at the blood–brain barrier
Dodelet-Devillers, A., Cayrol, R., van Horssen, J., Haqqani, A. S., de Vries, H. E., Engelhardt, B., Greenwood, J., & Prat, A. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0488-6 · Cited by 71
Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1
Sadowski, T., & Steinmeyer, J. (2001) · Inflammation Research · doi:10.1007/s000110050742 · Cited by 67
Oxidative Stress is Increased in Serum from Mexican Patients with Relapsing-Remitting Multiple Sclerosis
Ortíz, G. G., Macías-Islas, M. Á., Pacheco-Moisés, F. P., Cruz-Ramos, J. A., Sustersik, S., Barba, E. A., & Arelis, A. A. (2009) · Disease Markers · doi:10.1155/2009/325847 · Cited by 66
Self-citation
Molecular Basis of Leukocyte–Endothelium Interactions During the Inflammatory Response
Barreiro, O., & Sánchez‐Madrid, F. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71837-7 · Cited by 56
Phosphorylation of Blood Vessel Vasodilator-Stimulated Phosphoprotein at Serine 239 as a Functional Biochemical Marker of Endothelial Nitric Oxide/Cyclic GMP Signaling
Ibarra‐Alvarado, C., Galle, J., Melichar, V. O., Mameghani, A. T., & Schmidt, H. H. H. W. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.2.312 · Cited by 56
Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis.
Ortíz, G. G., Macías-Islas, M. Á., Pacheco-Moisés, F. P., et al. (2009) · PubMed · doi:10.3233/dma-2009-0602 · Cited by 53
Self-citation
Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis
Scott, G. S., Hake, P. W., Kean, R. B., Virág, L., Szabó, C., & Hooper, D. C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00329-0 · Cited by 51
Is MS an inflammatory or primary degenerative disease?
Losy, J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1079-9 · Cited by 50
Bases moleculares de las interacciones leucocito-endotelio durante la respuesta inflamatoria
Barreiro, O., & Sánchez‐Madrid, F. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)71035-8 · Cited by 47
Pro-inflammatory cytokines intensify the activation of NO/NOS, JNK1/2 and caspase cascades in immature neurons exposed to elevated levels of unconjugated bilirubin
Vaz, A. R., Silva, S. L., Barateiro, A. P., Fernandes, A. M. A., Falcão, A. S., Brito, M. A., & Brites, D. M. T. O. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.03.004 · Cited by 46
Methylprednisolone Acts on Peripheral Blood Mononuclear Cells and Endothelium in Inhibiting Migration Phenomena in Patients With Multiple Sclerosis
Gelati, M. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.774 · Cited by 45
Microglia: a cellular vehicle for CNS gene therapy
Neumann, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30230 · Cited by 41
“Thinking without thinking” about natalizumab and PML
Ransohoff, R. M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.04.011 · Cited by 33
Immune tolerance and control of CNS autoimmunity: from animal models to MS patients
Cassan, C., & Liblau, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04270.x · Cited by 32
Investigation of endosomal compartments involved in endocytosis and transcytosis of polymeric immunoglobulin A by subcellular fractionation of perfused isolated rat liver
Perez, J. H., Branch, W. J., Smith, L., Mullock, B. M., & Luzio, J. P. (1988) · Biochemical Journal · doi:10.1042/bj2510763 · Cited by 29
Multiple Redox Regulation of the Cellular Signaling System Linked to AP‐1 and NFκB: Effects of N‐Acetylcysteine and H2O2 on the Receptor Tyrosine Kinases, the MAP Kinase Cascade, and IκB Kinases
Kamata, H., Manabe, T., Kakuta, J., Oka, S., & Hirata, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04675.x · Cited by 27
The initiation of the autoimmune response in multiple sclerosis
Markovic‐Plese, S., Pinilla, C., & Martinꝉ, R. (2004) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2004.02.018 · Cited by 24
A study of the hydrogen ion concentration of the potato tuber
Robertson, I. M., & Smith, A. M. (1931) · Biochemical Journal · doi:10.1042/bj0250763 · Cited by 21
Natalizumab: overview of its pharmacology and safety.
Baker, D. E. (2007) · PubMed · Cited by 20
Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Spuch, C., & Fernández-Balbuena, C. N. (2010) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214811004030190 · Cited by 18
La barrera hematoencefálica y la administración de medicamentos en el sistema nervioso central
Neckel, G. L., & Koepp, J. (2010) · Revista de Neurología · doi:10.33588/rn.5103.2009166 · Cited by 15

Flagged first, then by citations

Research works printed but not linked: 1

Loch-Neckel, 2010, The blood-brain barrier and the drug delivery in the central nervous system, Rev Neurol, 51, 165

Sorted by citations

Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Multiple sclerosis
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology
Augustin, H. G., & Koh, G. Y. (2017) · Science · doi:10.1126/science.aal2379 · Cited by 790
The blood-brain barrier in aging and neurodegeneration
Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Lehmann‐Werman, R., Neiman, D., Zemmour, H., Moss, J., Magenheim, J., Vaknin‐Dembinsky, A., Rubertsson, S., Nellgård, B., Blennow, K., Zetterberg, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519286113 · Cited by 613

See all 385

Authors: Ortiz, G. G., Pacheco-Moisés, F. P., Macías-Islas, M. Á., Flores-Alvarado, L. J., Mireles-Ramírez, M. A., González-Renovato, E. D., Hernández-Navarro, V. E., Sánchez-López, A. L., & Alatorre-Jiménez, M. A.
Affiliations: Mexican Social Security Institute (MX)
Universidad de Guadalajara (MX)
ORCID: Macías-Islas, Miguel Ángel
Flores-Alvarado, Luis Javier
Mireles-Ramírez, Mario A.
Sánchez-López, Angélica Lizeth
Alatorre-Jiménez, Moisés Alejandro
Venue: Archives of Medical Research
Publisher: Elsevier BV
Published: 2014-11
Volume: 45
Issue: 8
Pages: 687-697
ISSN: 0066-6769 (ISSN-L)
0188-4409
DOI: 10.1016/j.arcmed.2014.11.013
OpenAlex: W2001448765
Cited by: 373
References: 88
Citations by year: 2026: 20 · 2025: 32 · 2024: 56 · 2023: 54 · 2022: 48 · 2021: 40 · 2020: 46 · 2019: 16 · 2018: 29 · 2017: 12 · 2016: 9 · 2015: 11
FWCI: 0.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Archives of Medical Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: multiple sclerosis, blood-brain barrier, demyelination, neuroinflammation, leukocyte transendothelial migration, brain endothelial cells, pericytes, astrocytes, perivascular macrophages, inflammatory cytokines, reactive oxygen and nitrogen species, myelin destruction, axonal loss, neurodegeneration
MeSH terms: Astrocytes, Blood-Brain Barrier, Cell Adhesion, Humans, Inflammation, Lymphocytes, Macrophages, Multiple Sclerosis, Cell Adhesion Molecules, Cytokines, Oxidative Stress, Endothelial Cells, Transendothelial and Transepithelial Migration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of the Blood–Brain Barrier in Multiple Sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks